MULTIPARAMETRIC
MRI & 3D Prostate Mapping
Prostate ultrasound has many uses, but it cannot accurately identify all prostate cancer tumors within the gland. Prostate ultrasound can only detect about 40% of prostate cancers. Multiparametric MRI has been shown to have a sensitivity (detection rate) of over 90% for clinically important prostate cancer when the study is performed with modern equipment and interpreted by highly skilled radiology physicians who have advanced training in the interpretation of these images.
With the use of advanced Magnetic Resonance Imaging (MRI) with modern MRI equipment, and multiparametric imaging software installed so that excellent quality prostate MRI studies are performed, Multiparametric MRI allows us to see the difference between healthy and cancerous prostate tissue with much higher accuracy than ultrasound. Multiparametric MRI at either 1.5 T or 3T gives us a 3-dimensional (3D) map of the prostate with the location, size and shape of suspected tumor(s).
When we integrate the information from biomarkers with MRI imaging, a more precise assessment of the risk of prostate cancer can be made and better advice can be given about the need for a prostate biopsy.
ARTEMIS
Technology Advantages
Precise Prostate Imaging & Navigation:
An Artemis-MRI/TRUS Fusion Biopsy offers the only true smart prostate biopsy procedure—providing your physician with 3D prostate visualization, precise needle tracking and biopsy location recording for future reference.
Advanced Diagnostic Data:
An Artemis-MRI/TRUS Fusion Biopsy allows physicians to examine, map, plan and record your biopsy. The detailed 3D provides precise location of suspicious tissue and/or cancer lesions. This results in advanced clinical information to aid in diagnosis, treatment and continuing care.
Better Treatment Information:
The Artemis-MRI/TRUS Fusion Biopsy provides clear, reliable information that can assist patients and physicians in making a more informed, individualized decision about the most appropriate course of care.
3D Patient Reporting:
At the conclusion of the Artemis-MRI/TRUS Fusion Biopsy, Artemis yields an easy-to-understand, high-definition colour report you can take home. It clearly identifies each biopsy sample location, along with more valuable information to help patients and physicians make the best, most informed treatment decision possible.
Accurate Repeat Biopsy:
With its unique biopsy location recording capability, your physician has the ability to re-biopsy the same locations in the gland or to sample other areas around any specific location. This helps ensure that any subsequent biopsies are more accurately sampled than ever before.
Long-term Personalized Management:
Since Artemis-MRI/Fusion Biopsy records the location of each biopsy sample, your physician is able to construct a personal baseline of data that greatly enhances future reference, confirmation and followup. The bottom line is better information for better long-term health care management.
